StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3027% below fair value
$96.43+2.52 (+2.68%)

Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%

TransMedics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

TransMedics's pe ratio was 23.9× on Nov 11, 2026, against 59.2× a year earlier. Over the last 2 years it ranged from 15.2× to 98.5×, with a median of 58.1×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202623.9×−25.4
2025Dec 31, 202549.3×−17.1
2024Dec 31, 202466.3×–

More TransMedics figures

See a number that looks wrong?